bristol-myers squibb co (BMY:New York)
Transactions by BRISTOL-MYERS SQUIBB CO (BMY) in the last 6 months
The Medicines Company (NasdaqGS:MDCO) agreed to acquire certain assets related to Recothrom from Bristol-Myers Squibb Company (NYSE:BMY) for $85 million on August 6, 2014. Medicines Company exercised its option to acquire certain assets, including certain patent and trademark rights, contracts, inventory, equipment and related books and records, held by Bristol-Myers Squibb which are exclusively related to Recothrom, and assume certain liabilities of Bristol-Myers Squibb ...
Allied-Bristol Life Sciences, LLC announced that it has received a round of funding from new investors Allied Minds plc and Bristol-Myers Squibb Company on August 3, 2014. The investors will each acquire 50% stake in the company through this transaction.
Bristol-Myers Squibb Company
|AbbVie Inc||$61.73 USD||-0.70|
|Biogen Idec Inc||$356.58 USD||-0.95|
|Celgene Corp||$123.01 USD||-0.88|
|Novo Nordisk A/S||kr297.10 DKK||+4.10|
|Thermo Fisher Scientific Inc||$123.95 USD||-0.92|
|View Industry Companies|